BioCentury | Oct 26, 2015
Company News

Commonwealth Laboratories, Quest Diagnostics sales and marketing update

...Commonwealth’s IBSchek is now available through Quest. The ELISA-based blood test detects antibodies against cytolethal distending toxin B (CdtB) and...
BioCentury | Sep 7, 2015
Company News

Commonwealth Laboratories, Valeant Pharmaceuticals deal

...an ELISA-based blood test to diagnose irritable bowel syndrome (IBS) by detecting antibodies against cytolethal distending toxin B (CdtB)...
BioCentury | Jul 13, 2015
Company News

Commonwealth Laboratories sales and marketing update

...blood test to diagnose irritable bowel syndrome (IBS). The laboratory-developed test (LDT) detects antibodies against cytolethal distending toxin B (CdtB)...
BioCentury | Dec 17, 2012
Emerging Company Profile

Haplogen: Mining for host factors

Haplogen GmbH is screening haploid human cells to identify new host factors required for bacterial or viral infection, which it hopes will lead to the development of anti-infectives with less potential for resistance. Haplogen was...
Items per page:
1 - 4 of 4